This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: ISTH News

October ISTH Webinar: von Willebrand Disease (VWD): new insights

Friday, September 19, 2014   (0 Comments)
Share |

Webinar registration is now open; register online today!


Date: October 15, 2014

Time: 2:00 - 3:00 PM GMT

*Check your time here.

 

Presenters:



David Lillicrap, MD FRCPC, Queen’s University, Kingston, Canada
Jeroen Eikenboom, MD, PhD, Leiden University Medical Center, The Netherlands



Translational insights into the molecular basis of von Willebrand disease – David Lillicrap
This presentation will focus on the advances made in understanding the molecular pathogenesis of von Willebrand disease (VWD) in the past two decades. The presentation will begin with a brief update on the fundamental knowledge of von Willebrand factor structure and function. This introduction will then be followed by a consideration of the molecular genetic pathology responsible for each of the subtypes of VWD. The presentation will highlight the strengths and weaknesses of current molecular genetic knowledge for VWD as it pertains to the potential for using this information in genetic diagnosis of this disorder. The presentation will end with a brief discussion of future lines of investigation required to further enhance our pathogenetic understanding of this multifaceted, complex genetic trait.


Diagnosis and management of von Willebrand disease – Jeroen Eikenboom
The presentation will address the diagnosis and management of von Willebrand disease (VWD). After a brief discussion of the classification of VWD the presentation will focus on the bleeding history, including the value of bleeding assessment tools and bleeding scores, the laboratory tests required for diagnosis as well as subtyping, and the potential new roles for ratios of von Willebrand factor (VWF) parameters and the VWF propeptide assay in the diagnostic work-up of VWD. In the second part of the presentation a practical approach to the treatment of VWD will be presented. At the end of the presentation the participants will be better prepared for the diagnosis and management of VWD.


 

Supported by an unrestricted educational grant from

 

Register now!

  

- and -


Vote on upcoming webinars!

Membership Management Software Powered by YourMembership  ::  Legal